polyclonal anti phospho insulin receptor substate 1 (Cell Signaling Technology Inc)
86
Structured Review
Cell Signaling Technology Inc
polyclonal anti phospho insulin receptor substate 1
Polyclonal Anti Phospho Insulin Receptor Substate 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti+phospho+insulin+receptor+substate+1/10__2139_slash_ssrn__4028976-94-1-12
Average 86 stars, based on 1 article reviews
Polyclonal Anti Phospho Insulin Receptor Substate 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti+phospho+insulin+receptor+substate+1/10__2139_slash_ssrn__4028976-94-1-12
Average 86 stars, based on 1 article reviews
polyclonal anti phospho insulin receptor substate 1 - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Western Blot:Article Title: Remodeling on Adipocytic Physiology Insights into the Endocrinal Disruption Effect of Organophosphorus Esters on Mature Adipocytes Article Snippet: 1 1 2 Remodeling on adipocytic physiology insights into the endocrinal disruption 3 effect of organophosphorus esters on mature adipocytes 4 5 Ying Liu a1, Yifei Le a1, Mengting Xu1, Wanyue Wang1, Hang Chen1, Quan Zhang2, 6 Cui Wang*1 7 8 1 School of Life Science, Zhejiang Chinese Medical University, Hangzhou 310053, 9 Zhejiang, People’s Republic of China 10 2 Key Laboratory of Microbial Technology for Industrial Pollution Control of 11 Zhejiang Province, College of Environment, Zhejiang University of Technology, 12 Hangzhou, Zhejiang, 310032, China.. 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 *To whom correspondence should be addressed.. Phone: +86 571 86613756; 32 E-mail: wangcui198506@163.com (C Wang) 33 a The authors made equal contribution to this work 2 34 35 Abstract 36 The emerging endocrine disruption chemicals organophosphate esters (OPEs) poses 37 high risk to glycolipid metabolism. |